drugset / Trial / NCT05990517
Autologous Transplantation of Expanded Pancreatic Islet Cells (YD01-2022) in Patients
NaSingle-groupOpen-labelTreatment
Summary
This study will evaluate the efficacy and safety of autologous transplantation of expanded pancreatic islet cells in patients with diabetes mellitus after total pancreatectomy.
Timeline
- Start
- 2023-02-22
- Primary completion
- 2024-08
- Completion
- 2025-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | YD01-2022 | Cell therapy | — | Other |